A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates
@article{Balafkan2020AMF, title={A method for differentiating human induced pluripotent stem cells toward functional cardiomyocytes in 96-well microplates}, author={Novin Balafkan and Sepideh Mostafavi and Manja Schubert and Richard Siller and Kristina Xiao Liang and Gareth John Sullivan and Laurence A. Bindoff}, journal={Scientific Reports}, year={2020}, volume={10} }
The capacity of pluripotent stem cells both for self-renewal and to differentiate into any cell type have made them a powerful tool for studying human disease. Protocols for efficient differentiation towards cardiomyocytes using defined, serum-free culture medium combined with small molecules have been developed, but thus far, limited to larger formats. We adapted protocols for differentiating human pluripotent stem cells to functional human cardiomyocytes in a 96-well microplate format. The…
12 Citations
Replating Protocol for Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
- Biology, EngineeringMethods in molecular biology
- 2021
Optimized protocols to dissociate hiPSC-CMs by using collagenase A&B, Collagenase II, TrypLE, and EDTA and reseeding on various matrix materials including fibronectin, laminin, imatrix, Matrigel, and Geltrex are defined.
The Human Induced Pluripotent Stem Cell Test as an Alternative Method for Embryotoxicity Testing
- BiologyInternational journal of molecular sciences
- 2022
A fetal bovine serum-free hiPSC-based in vitro test method, called the human induced pluripotent stem cell test (hiPS Test), is set up and characterized to evaluate the embryotoxic potential of substances.
2D graphene oxide particles induce unwanted loss in pluripotency and trigger early differentiation in human pluripotent stem cells.
- BiologyJournal of hazardous materials
- 2021
Nanotechnology in cardiac stem cell therapy: cell modulation, imaging and gene delivery
- BiologyRSC advances
- 2021
This review focuses on the major hurdles associated with cardiac stem cell therapy and the role of nanoparticles to overcome the major challenges in this field, including cell modulation, imaging, tracking and gene delivery.
Distinct Mitochondrial Remodeling During Mesoderm Differentiation in a Human-Based Stem Cell Model
- BiologyFrontiers in Cell and Developmental Biology
- 2021
It is found that mitochondrial content decreases continuously during mesoderm differentiation, despite increased mitochondrial activity and higher levels of ATP-linked respiration, and it is erroneous to assume that increased OXPHOS activity during differentiation requires a simultaneous expansion of mitochondrial content.
Distinct mitochondrial remodeling during early cardiomyocyte development in a human-based stem cell model
- BiologybioRxiv
- 2021
It is found that differentiated cardiomyocytes have significantly lower level of mitochondria content compared to their original source, pluripotent stem cells, although the efficiency of ATP generation via mitochondria respiration increases.
Cardiac Bio-Nanonetwork: Extracellular Vesicles Release Modeling for Engineered Stem Cell-Derived Cardiomyocyte
- Biology, EngineeringNANOCOM
- 2021
This paper proposes to use engineered human induced pluripotent stem cells differentiated into atrial cardiomyocytes (ACMs) in a cardiac bio-nanonetwork and mathematically model the release of therapeutic EVs under voltage clamp, and model the engineered ACMs as an EV emission model.
Harnessing Polyhydroxyalkanoates and Pressurized Gyration for Hard and Soft Tissue Engineering.
- Biology, EngineeringACS applied materials & interfaces
- 2021
This study confirms that engineered polyhydroxyalkanoate-based gyrospun fibers provide an exciting and unique toolbox for the development of scalable scaffolds for both hard and soft tissue regeneration.
Sars-Cov-2 Spike Protein-Induced Damage of hiPSC-Derived Cardiomyocytes.
- BiologyAdvanced biology
- 2022
When incubated with synthetic spike proteins of Sars-Cov-2, human-induced pluripotent stem cells (hiPSC), and a culture device made of an arrayed monolayer of cross-linked nanofibers, the damage of the spike protein on hiPSC-CMs is enhanced due to downregulated ACE2, chromatin margination, altered Connexin 43 expression, sarcomere disruption, and beating break.
Automated Feature Extraction from Large Cardiac Electrophysiological Data Sets
- BiologybioRxiv
- 2020
This work is able to show that action potentials from the same cell site can be recorded over days without detrimental effects to the cell membrane, and contributes towards a non-invasive approach for cardiomyocyte functional maturation, as well as developmental, pathological and pharmacological studies.
References
SHOWING 1-10 OF 55 REFERENCES
Chemically defined generation of human cardiomyocytes
- BiologyNature Methods
- 2014
This work systematically developed an optimized cardiac differentiation strategy, using a chemically defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate and rice-derived recombinant human albumin, which was effective in 11 hiPSC lines tested.
Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules.
- BiologyAdvances in biochemical engineering/biotechnology
- 2018
The development of directed and closely controlled cardiomyogenic differentiation is described, which now enables the induction of >90% CM purity without further lineage enrichment, and how this, in principle, unlimited source of human CMs can be used to progress heart regeneration and stimulate the drug discovery pipeline.
Small-Molecule-Driven Hepatocyte Differentiation of Human Pluripotent Stem Cells
- BiologyStem cell reports
- 2015
Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes.
- BiologyCell stem cell
- 2013
Nongenetic method for purifying stem cell–derived cardiomyocytes
- BiologyNature Methods
- 2010
It is found that a fluorescent dye that labels mitochondria, tetramethylrhodamine methyl ester perchlorate, could be used to selectively mark embryonic and neonatal rat cardiomyocytes, as well as mouse, marmoset and human PSC-derived cardiomers, and that the cells could subsequently be enriched (>99% purity) by fluorescence-activated cell sorting.
Chemically Defined and Small Molecule-Based Generation of Human Cardiomyocytes
- BiologyNature methods
- 2014
This work systematically developed a highly optimized cardiac differentiation strategy, employing a chemically defined medium consisting of just three components: the basal medium RPMI 1640, L-ascorbic acid 2-phosphate, and ricederived recombinant human albumin, and was effective in 11 hiPSC lines tested.
Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview.
- BiologyCirculation research
- 2012
The basic biology underlying the differentiation of pluripotent cells to cardiac lineages is reviewed and current state-of-the-art protocols are described, as well as ongoing refinements.
Two dimensional electrophysiological characterization of human pluripotent stem cell-derived cardiomyocyte system
- BiologyScientific reports
- 2017
The electrophysiological maturation of the human pluripotent stem cell-derived cardiomyocytes in this system recapitulates in vivo development and provides a versatile biological tool to analyze human heart development, disease mechanisms, and the efficacy/toxicity of chemicals.
Generation of Highly Purified Human Cardiomyocytes from Peripheral Blood Mononuclear Cell-Derived Induced Pluripotent Stem Cells
- BiologyPloS one
- 2015
A combined and optimized protocol combining the derivation of iPS from peripheral blood with an optimized directed differentiation to cardiomyocytes and a subsequent metabolic selection is developed, which is highly robust and applicable for scalable cardiac differentiation.
SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells
- BiologyNature Biotechnology
- 2011
This screen identified the signal-regulatory protein alpha (SIRPA) as a marker expressed specifically on cardiomyocytes derived from hESCs and human induced pluripotent stem cells (hiPSCs), and PECAM, THY1, PDGFRB and ITGA1 as markers of the nonmyocyte population.